M Ventures
Venture capitalLos Angeles · Seed–Series A · 11 people tracked
Team · 11 people
from the firm's websiteWhat they invest in
from 8 of 92 portfolio companiesDeep Tech ×5AI & Machine Learning ×4Biotech ×4Medical Devices ×3Cloud Computing ×2Enterprise Software ×2Consumer ×1Cybersecurity ×1
HQs:United States×5
Investments · showing 60 of 92
founders shown can be your intro pathAnjuna develops software for secure data sharing and confidential computing in cloud and AI environments. The company serves enterprises seeking to protect data while leveraging cloud and artificial intelligence capabilities.
AI & Machine LearningCloud ComputingCybersecurityDeep TechEnterprise SoftwareSan Francisco, US
Ayal Yogev(Founder/CEO)inMark VaskevichSteve Weis
Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech. The company focuses on drug candidates targeting ovarian and pancreatic cancer.
BiotechDeep TechMedical Devices
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples. The company serves research and diagnostic laboratories in the life sciences and precision oncology fields.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)Jiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)
Mostbet is a mobile betting and casino platform offering sports betting, casino games, poker, and virtual sports accessible via Android and iOS apps as well as web browsers. The platform operates as a licensed online gambling service available in over 90 countries.
ConsumerGamingLos Angeles, US
Alexander Mistakidis(Founder/CEO)inCarter Minshull(Founder/CTO)in
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies. The company is building on research from academic institutions including Dana Farber Cancer Institute and MIT.
BiotechDigital HealthMedical Devices
Lightcast develops Envisia, a next-generation platform for single-cell functional screening and analysis that enables researchers to study biomolecule secretion, cell-cell interactions, and targeted cell killing at scale. The platform serves biotech and pharmaceutical companies working on therapeutic discovery and development.
AI & Machine LearningBiotechDeep Tech
Frequently asked questions
- What stage does M Ventures invest at?
- M Ventures invests at the Seed, Series A stages.
- What is M Ventures's typical check size?
- M Ventures typically writes checks of $10.8M.
- What sectors does M Ventures focus on?
- M Ventures focuses on Biotech, Hardware, Medical Devices, New Materials.
- Where is M Ventures located?
- M Ventures is headquartered in Los Angeles, US.